SuperworthArcus Biosciences shares outstanding RCUS
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 126.1M
- On a year earlier
- +18.4%
- more shares
Arcus Biosciences had 126.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 18.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 118.4M | +29% |
| FY2024 | 91.6M | +22% |
| FY2023 | 75.2M | +3% |
| FY2022 | 72.7M | −3% |
| FY2021 | 75M | +18% |
| FY2020 | 63.5M | +44% |
| FY2019 | 44.1M | +2% |
| FY2018 | 43.2M | +1852% |
| FY2017 | 2.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 126.1M | +18% | |
| Q1 FY26 | 125.4M | +27% | |
| Q4 FY25 | 118.4M | +29% | |
| Q3 FY25 | 106.5M | +17% | |
| Q2 FY25 | 106.5M | +17% | |
| Q1 FY25 | 98.4M | +14% | |
| Q4 FY24 | 91.6M | +22% | |
| Q3 FY24 | 91.4M | +23% | |
| Q2 FY24 | 91.1M | +24% | |
| Q1 FY24 | 86.2M | +18% | |
| Q4 FY23 | 75.2M | +3% | |
| Q3 FY23 | 74.6M | +3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Arcus Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.